Private Trust CO Na Gilead Sciences, Inc. Transaction History

Private Trust CO Na

$964 Million
Q3 2024

A detailed history of Private Trust CO Na transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Private Trust CO Na holds 4,861 shares of GILD stock, worth $438,413. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,861

Previous 4,922 1.24%

Holding current value

$438,413

Previous $337,000 20.77%

% of portfolio

0.04%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $4,061 - $5,123	-61 Reduced 1.24%	4,861 $407,000
Q2 2024 Jul 23, 2024	SELL	$63.15 - $72.88 $98,198 - $113,328	-1,555 Reduced 24.01%	4,922 $337,000
Q1 2024 Apr 24, 2024	BUY	$71.58 - $87.29 $37,150 - $45,303	519 Added 8.71%	6,477 $474,000
Q4 2023 Jan 24, 2024	SELL	$73.27 - $83.09 $1,685 - $1,911	-23 Reduced 0.38%	5,958 $482,000
Q3 2023 Oct 18, 2023	BUY	$73.94 - $80.67 $5,915 - $6,453	80 Added 1.36%	5,981 $448,000
Q2 2023 Jul 28, 2023	BUY	$76.01 - $86.7 $41,425 - $47,251	545 Added 10.18%	5,901 $454,000
Q1 2023 Apr 12, 2023	SELL	$77.31 - $88.08 $134,519 - $153,259	-1,740 Reduced 24.52%	5,356 $444,000
Q4 2022 Jan 18, 2023	SELL	$62.32 - $89.47 $8,600 - $12,346	-138 Reduced 1.91%	7,096 $0
Q3 2022 Oct 17, 2022	BUY	$59.54 - $68.01 $67,101 - $76,647	1,127 Added 18.45%	7,234 $446,000
Q2 2022 Sep 16, 2022	BUY	$57.72 - $65.01 $22,106 - $24,898	383 Added 6.69%	6,107 $377,000
Q1 2022 Apr 12, 2022	SELL	$57.92 - $72.58 $102,750 - $128,756	-1,774 Reduced 23.66%	5,724 $340,000
Q4 2021 Jan 10, 2022	SELL	$64.88 - $73.64 $14,273 - $16,200	-220 Reduced 2.85%	7,498 $544,000
Q3 2021 Oct 06, 2021	BUY	$67.69 - $73.03 $14,417 - $15,555	213 Added 2.84%	7,718 $539,000
Q2 2021 Jul 07, 2021	SELL	$63.47 - $69.35 $45,888 - $50,140	-723 Reduced 8.79%	7,505 $516,000
Q1 2021 Apr 06, 2021	BUY	$60.0 - $68.46 $55,560 - $63,393	926 Added 12.68%	8,228 $531,000
Q4 2020 Jan 05, 2021	BUY	$56.65 - $64.55 $141,681 - $161,439	2,501 Added 52.09%	7,302 $425,000
Q3 2020 Oct 01, 2020	BUY	$62.1 - $78.08 $81,288 - $102,206	1,309 Added 37.49%	4,801 $303,000
Q2 2020 Jul 07, 2020	SELL	$72.34 - $84.0 $122,326 - $142,044	-1,691 Reduced 32.63%	3,492 $268,000
Q1 2020 Apr 07, 2020	BUY	$62.63 - $80.22 $74,341 - $95,221	1,187 Added 29.7%	5,183 $387,000
Q4 2019 Jan 02, 2020	SELL	$61.62 - $67.78 $308 - $338	-5 Reduced 0.12%	3,996 $259,000
Q3 2019 Oct 01, 2019	BUY	$62.51 - $69.0 $61,947 - $68,379	991 Added 32.92%	4,001 $253,000
Q2 2019 Jul 02, 2019	BUY	$61.87 - $69.38 $186,228 - $208,833	3,010 New	3,010 $0
Q4 2018 Jan 03, 2019	SELL	$60.54 - $79.0 $192,396 - $251,062	-3,178 Closed	0 $0
Q3 2018 Oct 09, 2018	SELL	$71.28 - $78.92 $39,417 - $43,642	-553 Reduced 14.82%	3,178 $0
Q2 2018 Jul 03, 2018	BUY	$64.88 - $75.68 $4,995 - $5,827	77 Added 2.11%	3,731 $0
Q1 2018 Apr 03, 2018	BUY	$72.84 - $88.8 $4,443 - $5,416	61 Added 1.7%	3,654 $0
Q4 2017 Jan 16, 2018	SELL	$71.15 - $83.52 $11,739 - $13,780	-165 Reduced 4.39%	3,593 $0
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $270,989 - $321,196	3,758	3,758 $0

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.

Account

Private Trust CO Na Gilead Sciences, Inc. Transaction History